A61K 35/66
Microorganisms or materials therefrom
Official title: Microorganisms or materials therefrom (fungi, yeasts or candida A61K36/06)
A61K35/66 (Microorganisms or materials therefrom) appears on 6,236 US grants and 12,257 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,236
- Published applications
- 12,257
- Assignees
- 3,890
- Inventors
- 18,097
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 20 | 0 |
| 1978 | 4 | 0 |
| 1979 | 8 | 0 |
| 1980 | 13 | 0 |
| 1981 | 4 | 0 |
| 1982 | 13 | 0 |
| 1983 | 4 | 0 |
| 1984 | 10 | 0 |
| 1985 | 12 | 0 |
| 1986 | 5 | 0 |
| 1987 | 9 | 0 |
| 1988 | 7 | 0 |
| 1989 | 11 | 0 |
| 1990 | 5 | 0 |
| 1991 | 7 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 9 | 0 |
| 1995 | 13 | 0 |
| 1996 | 15 | 0 |
| 1997 | 18 | 0 |
| 1998 | 34 | 0 |
| 1999 | 26 | 0 |
| 2000 | 37 | 0 |
| 2001 | 47 | 20 |
| 2002 | 52 | 97 |
| 2003 | 60 | 108 |
| 2004 | 52 | 170 |
| 2005 | 38 | 181 |
| 2006 | 58 | 156 |
| 2007 | 63 | 165 |
| 2008 | 47 | 194 |
| 2009 | 59 | 219 |
| 2010 | 87 | 261 |
| 2011 | 111 | 297 |
| 2012 | 117 | 305 |
| 2013 | 177 | 354 |
| 2014 | 186 | 406 |
| 2015 | 206 | 420 |
| 2016 | 265 | 504 |
| 2017 | 300 | 583 |
| 2018 | 350 | 630 |
| 2019 | 378 | 830 |
| 2020 | 445 | 949 |
| 2021 | 475 | 984 |
| 2022 | 538 | 1041 |
| 2023 | 500 | 929 |
| 2024 | 460 | 999 |
| 2025 | 499 | 839 |
| 2026 | 362 | 616 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tumor-targeting Salmonella gallinarum strain and use thereof6 Oct 2026US 12,751,978 B2Industry Foundation of Chonnam National University
- Composition for preventing or treating inflammatory bowel disease6 Oct 2026US 12,751,979 B2Ajou University Industry-Academic Cooperation Foundation
- Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation6 Oct 2026US 12,751,980 B2Jiangnan University
- Composition for improving the microbiome6 Oct 2026US 12,751,981 B2Iiaa Limited
- Bacteriophage effective for controlling Salmonella typhimurium and its derived biofilm, and an antibacterial composition comprising the same6 Oct 2026US 12,751,982 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Probiotic-fortified, high-protein food product and method of making same8 Oct 2026US 2026/0305659 A1
- Method of addressing alzheimer's disease or non-alzheimer's dementia8 Oct 2026US 2026/0305670 A1G. Nofar Food Agency Ltd.
- Pharmaceutical combination for cancer treatment8 Oct 2026US 2026/0306466 A1Miyarisan Pharmaceutical Co., Ltd.
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Recombinant expression vector for interferon-beta secretion and attenuated salmonella strain transformed by means of same8 Oct 2026US 2026/0306554 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Compositions and methods239US 9,011,834 B1Seres Health, Inc. · 2015
- Treatment of gastro-intestinal disorders232US 6,645,530 B1Gastro Services Pty Ltd. · 2003